Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 21, 2026 20:07 ET | Source: Robbins LLP

Robbins LLP Encourages STLA Investors to Contact the Firm for Information About the Class Action Against Stellantis N.V.

Robbins LLP is Investigating Allegations that Stellantis N.V. (STLA) Misled Investors Regarding its 2025 Earnings Projections
May 21, 2026 20:05 ET | Source: Robbins LLP

Robbins LLP Reminds UHG Investors of the Pending Class Action Lawsuit; Harmed Investors Should Contact the Firm for Information About Leading the Class Action Against United Homes Group, Inc.

Robbins LLP is Investigating Allegations that United Homes Group, Inc. (UHG) Misled Investors Regarding the Forthcoming Sale of the Company
May 21, 2026 19:12 ET | Source: Robbins LLP

Robbins LLP Encourages UPST Investors to Contact the Firm for Information About the Class Action Against Upstart Holdings, Inc.

Robbins LLP is Investigating Allegations that Upstart Holdings, Inc. (UPST) Misled Investors Regarding its Business Prospects
May 21, 2026 19:08 ET | Source: Robbins LLP

CVLT Class Action Notice: Robbins LLP Reminds Investors of the Lead Plaintiff Deadline in the Commvault Systems, Inc. Class Action Lawsuit

Robbins LLP is Investigating Allegations that Commvault Systems, Inc. (CVLT) Misled Investors Regarding its Annualized Recurring Revenue Growth
May 21, 2026 18:51 ET | Source: Robbins LLP

CHX Class Action Notice: Robbins LLP Reminds Investors of the Lead Plaintiff Deadline in the ChampionX Corporation Class Action Lawsuit

Robbins LLP is Investigating Allegations that ChampionX Corporation (CHX) Repurchased Shares of its Stock in Violation of Securities Laws
May 20, 2026 16:21 ET | Source: Robbins LLP

Robbins LLP Reminds ALDX Investors of the Pending Class Action Lawsuit; Harmed Investors Should Contact the Firm for Information About Leading the Class Action Against Aldeyra Therapeutics, Inc.

Robbins LLP is Investigating Allegations that Aldeyra Therapeutics, Inc. (ALDX) Misled Investors Regarding its Lead Drug Candidate
May 20, 2026 16:08 ET | Source: Robbins LLP

Robbins LLP Reminds GOSS Investors of the Pending Class Action Lawsuit; Harmed Investors Should Contact the Firm for Information About Leading the Class Action Against Gossamer Bio, Inc.

Robbins LLP is Investigating Allegations that Gossamer Bio, Inc. (GOSS) Misled Investors Regarding the Viability of its PROSERA Study
May 18, 2026 18:27 ET | Source: Robbins LLP

PHR Class Action Notice: Robbins LLP Reminds Investors of the Lead Plaintiff Deadline in the Phreesia, Inc. Class Action Lawsuit

Robbins LLP is Investigating Allegations that Phreesia, Inc. (PHR) Misled Investors Regarding the Sustainability of Growth in its Network Solutions
May 18, 2026 17:34 ET | Source: Robbins LLP

POET Stockholders Have Rights – If You Lost Money Investing in POET Technologies Inc. Contact Robbins LLP for Information About Recovering Your Losses

Robbins LLP is Investigating Allegations that POET Technologies Inc. (POET) Misled Investors Regarding its Status as a Passive Foreign Investment Company
May 14, 2026 17:37 ET | Source: Robbins LLP

IMMP Class Action Notice: Robbins LLP Reminds Investors of the Lead Plaintiff Deadline in the Immutep Limited Class Action Lawsuit

Robbins LLP is Investigating Allegations that Immutep Limited (IMMP) Misled Investors Regarding the Viability and Efficacy of its Drug Candidate